These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25434695)

  • 21. Cytomorphology of non-small cell lung carcinoma with anaplastic lymphoma kinase gene rearrangement.
    Toll AD; Maleki Z
    Diagn Cytopathol; 2015 Jan; 43(1):8-15. PubMed ID: 24723496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.
    Hutarew G; Hauser-Kronberger C; Strasser F; Llenos IC; Dietze O
    Histopathology; 2014 Sep; 65(3):398-407. PubMed ID: 24612196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.
    Califano R; Abidin A; Tariq NU; Economopoulou P; Metro G; Mountzios G
    Cancer Treat Rev; 2015 May; 41(5):401-11. PubMed ID: 25842168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
    Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
    Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective screening for ALK: clinical features and outcome according to ALK status.
    Fallet V; Cadranel J; Doubre H; Toper C; Monnet I; Chinet T; Oliviero G; Foulon G; De Cremoux H; Vieira T; Antoine M; Wislez M
    Eur J Cancer; 2014 May; 50(7):1239-46. PubMed ID: 24589437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR gene mutations in patients with adenosquamous lung carcinoma.
    Powrózek T; Krawczyk P; Ramlau R; Sura S; Wojas-Krawczyk K; Kucharczyk T; Walczyna B; Szumiło J; Szyszka-Barth K; Milecki P; Barinow-Wojewódzki A; Milanowski J
    Asia Pac J Clin Oncol; 2014 Dec; 10(4):340-5. PubMed ID: 24575772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer.
    Johung KL; Yao X; Li F; Yu JB; Gettinger SN; Goldberg S; Decker RH; Hess JA; Chiang VL; Contessa JN
    Clin Cancer Res; 2013 Oct; 19(19):5523-32. PubMed ID: 23897899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic features of patients with non-small cell lung cancer harboring the EML4-ALK fusion gene: a meta-analysis.
    Wang Y; Wang S; Xu S; Qu J; Liu B
    PLoS One; 2014; 9(10):e110617. PubMed ID: 25360721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
    Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
    Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
    Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
    Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer.
    Mori M; Hayashi H; Fukuda M; Honda S; Kitazaki T; Shigematsu K; Matsuyama N; Otsubo M; Nagayasu T; Hashisako M; Tabata K; Uetani M; Ashizawa K
    Thorac Cancer; 2019 Apr; 10(4):872-879. PubMed ID: 30811109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer.
    Putora PM; Szentesi K; Glatzer M; Rodriguez R; Müller J; Baty F; Früh M
    Oncol Res Treat; 2016; 39(11):681-686. PubMed ID: 27855379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?
    Ou SH
    J Clin Pathol; 2013 Oct; 66(10):839-46. PubMed ID: 23661716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.
    Ruano-Ravina A; Torres-Durán M; Kelsey KT; Parente-Lamelas I; Leiro-Fernández V; Abdulkader I; Abal-Arca J; Montero-Martínez C; Vidal-García I; Amenedo M; Castro-Añón O; Golpe-Gómez A; González-Barcala J; Martínez C; Guzmán-Taveras R; Provencio M; Mejuto-Martí MJ; Fernández-Villar A; Barros-Dios JM
    Eur Respir J; 2016 Nov; 48(5):1462-1470. PubMed ID: 27799390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer.
    Chen Y; Li G; Lei Y; Yang K; Niu H; Zhao J; He R; Ning H; Huang Q; Zhou Q; Huang Y
    Thorac Cancer; 2019 Apr; 10(4):695-707. PubMed ID: 30775858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study.
    Obradović J; Djordjević N; Tošic N; Mrdjanović J; Stanković B; Stanić J; Zarić B; Perin B; Pavlović S; Jurišić V
    Tumour Biol; 2016 Aug; 37(8):10479-86. PubMed ID: 26846215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and/or Fluorescence-in-situ Hybridisation (FISH)].
    von Laffert M; Schirmacher P; Warth A; Weichert W; Büttner R; Huber RM; Wolf J; Griesinger F; Dietel M; Grohé Ch
    Pneumologie; 2016 Apr; 70(4):277-81. PubMed ID: 26984109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.
    Russell PA; Rogers TM; Solomon B; Alam N; Barnett SA; Rathi V; Williams RA; Wright GM; Conron M
    Pathology; 2017 Oct; 49(6):604-610. PubMed ID: 28811082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE.
    Rusu-Cordunean F; Berlea ML; Cernomaz AT; Marinca MV; Peter S; Pavel I; Grigoriu BD
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1031-6. PubMed ID: 26793845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.